Browse > Article

Clinical significance of cerebrospinal fluid pleocytosis in pediatric refractory status epilepticus  

Kim, Jung Mi (Departments of Pediatrics, College of Medicine, Kyungpook National University)
Kim, Young Mi (Departments of Pediatrics, College of Medicine, Kyungpook National University)
Kwon, Soon Hak (Departments of Pediatrics, College of Medicine, Kyungpook National University)
Publication Information
Clinical and Experimental Pediatrics / v.49, no.10, 2006 , pp. 1086-1092 More about this Journal
Abstract
Purpose : Refractory status epilepticus(RSE) is a serious neurological emergency in children. The mortality is high and the neurological outcome is not good. This study aimed to evaluate the clinical significance of cerebrospinal fluid(CSF) pleocytosis in refractory status epilepticus in children. Methods : From January 1999 to January 2006, 25 out of 37 children with refractory status epilepticus had spinal tapping. We retrospectively analyzed the data from these children's medical records. We compared the results between groups with and without CSF pleocytosis, and between a group with first seizure and a group with epilepsy. Result : Six out of 25 children had CSF pleocytosis. The group without CSF pleocytosis had a higher mortality rate and required higher doses of antiepileptic drugs as compared with the group with CSF pleocytosis. The group with CSF pleocytosis had much worse neurologic segualae. However, except for the children with CNS infection, the overall prognosis between the group with and without CSF pleocytosis was not significantly different. All children with CSF pleocytosis came in with first seizures. Conclusion : In children with RSE, a CSF study must be perfomed as soon as possible to exclude the possibility of CNS infection. A CSF study is even more important in cases of first seizure or CNS infection suspected. Mild CSF pleocytosis without evidence of infection does not seem to affect the prognosis, so physicians should therefore be more cautious in selecting antibacterial or antiviral agents for it.
Keywords
Refractory status epilepticus; Children; CSF pleocytosis; Prognosis; Mortality;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Osorio I, Reed RC. Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin. Epilepsia 1989;30:464-71   DOI   ScienceOn
2 Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996;37:863-7   DOI   ScienceOn
3 Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus : frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59:205-10   DOI   ScienceOn
4 Sahin M, Menache CC, Holmes GL, Riviello JJ, Jr. Prolonged treatment for acute symptomatic refractory status epilepticus : outcome in children. Neurology 2003;61:398-401   DOI   ScienceOn
5 Bleck TP. Advances in the management of refractory status epilepticus. Crit Care Med 1993;21:955-7   DOI   ScienceOn
6 Hamm SC, Kim CY . Clinical study of status epilepticus in children. J Korean Pediatr Soc 1990;33:790-5
7 Kalviainen R, Eriksson K, Parviainen I. Refractory generalised convulsive status epilepticus : a guide to treatment. CNS Drugs 2005;19:759-68   DOI   ScienceOn
8 van Gestel JP, Blusse van Oud-Alblas HJ, Malingre M, Ververs FF, Braun KP, van Nieuwenhuizen O. Propofol and thiopental for refractory status epilepticus in children. Neurology 2005;65:591-2   DOI   ScienceOn
9 Kim SY, Kim JK, Lee JH. A Pediatric case of topiramate treatment for treatment for refractory status epilepticus. J Korean Epilepsy Soc 2004;8:171-4
10 Oh HA, Kim CJ, Park KW, Woo YJ. The effect of intravenous continuous infusion midazolam against refractory status epilepticus in children. J Korean Child Neurol Soc 2000;8:80-6
11 Wilder-Smith EP, Lim EC, Teoh HL, Sharm VK, Tan JJ, Chan BP, et al. The NORSE(new-onset refractory status epilepticus) syndrome : defining a disease entity. Ann Acad Med Singapore 2005;34:417-20
12 Chen JW, Wasterlain CG. Status epilepticus : pathophysiology and management in adults. Lancet Neurol 2006; 5:246-56   DOI   ScienceOn
13 Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 2004;45:757-63   DOI   ScienceOn
14 Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980;69:657-66   DOI   ScienceOn
15 Kang YK, Kim SJ. The clinical characteristics of status epilepticus in children. J Korean Child Neurol Soc 1999;7: 71-8
16 Barry E, Hauser WA. Pleocytosis after status epilepticus. Arch Neurol 1994;51:190-3   DOI   ScienceOn
17 Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005;76:534-9   DOI   ScienceOn
18 Lee SE, Kim HS, Yoo HJ. Study of priority between prognostic factors of status epilepticus in childhood. J Korean Child Neurol Soc 2005;13:15-22
19 Simon RP. Physiologic consequences of status epilepticus. Epilepsia 1985;26 Suppl 1:S58-66   DOI   ScienceOn
20 Marik PE, Varon J. The management of status epilepticus. Chest 2004;126:582-91   DOI   ScienceOn
21 Schmidley JW, Simon RP. Postictal pleocytosis. Ann Neurol 1981;9:81-4   DOI   ScienceOn
22 Hanhan UA, Fiallos MR, Orlowski JP. Status epilepticus. Pediatr Clin North Am 2001;48:683-94   DOI
23 Robakis TK, Hirsch LJ. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 2006;4:35-46   DOI   ScienceOn
24 Lee KE, Kim WS. A Clinical study of acute symptomatic seizures in children. J Korean Pediatr Soc 2000;43:1254-62
25 Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia 2001;42:1461-7.   DOI   ScienceOn
26 Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993;34 Suppl 1:S37-53   DOI   ScienceOn
27 Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam : a systematic review. Epilepsia 2002;43:146- 53   DOI   ScienceOn
28 Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus : effect of treatment aggressiveness on prognosis. Arch Neurol 2005;62:1698-702   DOI   ScienceOn